Multimodal MRI Response to Fingolimod in Multiple Sclerosis: A Nonrandomized, Single Arm, Observational Study
Article in Journal of Neuroimaging (December 2020)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study
Article in Multiple Sclerosis and Related Disorders (December 2020)
Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia
Article in Brain Imaging and Behavior (September 2020)